Cerebral Ischemic Complications of Surgical Treatment in Patients with Moyamoya Disease
- PMID: 40632257
- DOI: 10.1007/978-3-031-89844-0_10
Cerebral Ischemic Complications of Surgical Treatment in Patients with Moyamoya Disease
Abstract
Objective: We aimed to identify unfavorable prognostic factors for the development of cerebral ischemic complications of surgical treatment in patients with moyamoya disease.
Methods: We analyzed 80 patients with moyamoya disease, who underwent 134 surgical revascularizations. Persistent complications (ischemic strokes) developed in seven cases (5.3%). In 36 cases (27%), there were short-term episodes of transient neurologic deficit.
Results: The statistical analysis revealed factors associated with the development of transient and persistent ischemic complications: neuroradiological "ivy sign" (χ2 = 4.078, p = 0.043), stenosis of the ICA proximal to the PComA or PCA (χ2 = 20.085, p < 0.0001), decompensation of cerebral blood flow (χ2 = 11.212, p < 0.001), recent CVA (less than 3 months before surgery) or instability of neurological symptoms (χ2 = 6.146, p < 0.013). Significant factors of the development of persistent ischemic stroke were as follows: stenosis or occlusion of the ipsilateral PCA (increasing the risk of stroke by 9.7 times); signs of the decompensation of cerebral perfusion (increased risk by 5.4 times); and unstable clinical symptoms within 3 months before surgery (increased risk by 6.4 times). The presence of at least two signs defines a group of patients that has an increased risk of complications with a sensitivity of 80.7% and a specificity of 88.6%.
Conclusion: The identified risk factors will enable predicting the risk of perioperative ischemic complications in patients with moyamoya disease and optimize management tactics and improve the results of surgical treatment.
Keywords: Combined revascularization; Extra-intracranial microanastomosis; Ischemic stroke; Moyamoya disease; Perioperative complications; Surgical revascularization.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: No conflict of interests to declare. Informed consent: For this type of study, formal consent is not required. Informed consent: Informed consent was obtained from all individual participants included in the study. Human and animal rights: This chapter does not contain any studies with animals performed by any of the authors.
References
-
- Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK. Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg. 2009;111(5):927–35. https://doi.org/10.3171/2009.4.JNS081649 . - PubMed
-
- Iwama T, Hashimoto N, Tsukahara T, Murai B. Peri-operative complications in adult moyamoya disease. Acta Neurochir. 1995;132(1–3):26–31. https://doi.org/10.1007/BF01404844 . - PubMed
-
- Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg. 1997;85(5):1060–5. https://doi.org/10.1097/00000539-199711000-00018 . - PubMed
-
- Starke RM, Komotar RJ, Connolly ES. Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. Neurosurg Focus. 2009;26(4):E8. https://doi.org/10.3171/2009.01.FOCUS08309 . - PubMed
-
- Jung YJ, Ahn JS, Kwon DH, Kwun BD. Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease. J Korean Neurosurg Soc. 2011;50(6):492–6. https://doi.org/10.3340/jkns.2011.50.6.492 . - PubMed - PMC
MeSH terms
LinkOut - more resources
Medical
Miscellaneous